MENU

Academic activities 2018

2018

Articles

  • Casati S, Aschberger K, Barroso J, Casey W, Delgado I, Kim TS, Kleinstreuer N, Kojima H, Lee JK, Lowit A, Park HK, Régimbald-Krnel MJ, Strickland J, Whelan M, Yang Y, Zuang V: Standardisation of defined approaches for skin sensitisation testing to support regulatory use and international adoption: position of the International Cooperation on Alternative Test Methods. Arch Toxicol. 2018 Feb;92(2):611-617.
  • Tsukumo H, Matsunari N, Yamashita K, Kojima H, Itagaki H: Lipopolysaccharide interferes with the use of the human Cell Line Activation Test to determine the allergic potential of proteins. J Pharmacol Toxicol Methods. 2018 Feb 10;92:34-42.
  • Koyama S, Arakawa H, Itoh M, Masuda N, Yano K, Kojima H, Ogihara T: Evaluation of the metabolic capability of primary human hepatocytes in three-dimensional cultures on microstructural plates. Biopharm Drug Dispos. 2018 Apr;39(4):187-195.
  • Daniel AB, Strickland J, Allen D, Casati S, Zuang V, Barroso J, Whelan M, Régimbald-Krnel MJ, Kojima H, Nishikawa A, Park HK, Lee JK, Kim TS, Delgado I, Rios L, Yang Y, Wang G, Kleinstreuer N: International regulatory requirements for skin sensitization testing. Regul Toxicol Pharmacol. 2018;95:52-65.
  • Dent M, Amaral RT, Da Silva PA, Ansell J, Fanny Boisleve, Hatao M, Hirose A, Kasai Y, Kern P, Kreiling R, Milstein S, Montemayor B, Oliveira J, Richarz A, Taalman R, Vaillancourt E, Verma R, Posada N.V.O.C, Weiss C, Kojima H: Principles underpinning the use of new methodologies in the risk assessment of cosmetic ingredients, Computational Toxicology, 2018(7), 20–26.
  • Narita K, Ishii Y, Vo PTH, Nakagawa F, Ogata S, Yamashita K, Kojima H, Itagaki H.: Improvement of human cell line activation test (h-CLAT) using short-time exposure methods for prevention of false-negative results. J Toxicol Sci. 2018;43(3):229-240.
  • Hoffmann S, Kleinstreuer N, Alépée N, Allen D, Api AM, Ashikaga T, Clouet E, Cluzel M, Desprez B, Gellatly N, Goebel C, Kern PS, Klaric M, Kühnl J, Lalko JF, Martinozzi-Teissier S, Mewes K, Miyazawa M, Parakhia R, van Vliet E, Zang Q, Petersohn D: Non-animal methods to predict skin sensitization (I): the Cosmetics Europe database. Crit. Rev. Toxicol. 2018;48(5):344-358.
  • Kleinstreuer NC, Hoffmann S, Alépée N, Allen D, Ashikaga T, Casey W, Clouet E, Cluzel M, Desprez B, Gellatly N, Göbel C, Kern PS, Klaric M, Kühnl J, Martinozzi-Teissier S, Mewes K, Miyazawa M, Strickland J, van Vliet E, Zang Q, Petersohn D: Non-animal methods to predict skin sensitization (II): an assessment of defined approaches. Crit. Rev. Toxicol. 2018;48(5):359-374.
  • Dent M, Amaral RT, Da Silva PA, Ansell J, Fanny Boisleve, Hatao M, Hirose A, Kasai Y, Kern P, Kreiling R, Milstein S, Montemayor B, Oliveira J, Richarz A, Taalman R, Vaillancourt E, Verma R, Posada N.V.O.C, Weiss C, Kojima H: Principles underpinning the use of new methodologies in the risk assessment of cosmetic ingredients, Computational Toxicology, 2018(7), 20–26.
  • Kimura Y, Watanabe M, Suzuki N, Iwaki T, Yamakage K, Saito K, Nakajima Y, Fujimura C, Ohmiya Y, Omori T, Kojima H, Aiba S: The performance of an in vitro skin sensitisation test, IL-8 Luc assay (OECD442E), and the integrated approach with direct peptide reactive assay (DPRA), J Toxicol Sci. 2018; 43(12):741-749.

Presentations, Speeches

  • Kojima H, Furukawa M, Itoh K, Sakakibara T, Matsuura M: An Approach for Assessing Mild Irritants with the Bovine Corneal Opacity and Permeability Test Method, 57th Annual meeting of Society of Toxicology (2018.3) (San Antonio, USA)
  • Ono A, Watanabe S, Sugawara T, Wakabayashi K, Tahara Y, Horie N, Fujimoto K, Kusakari K, Kurokawa Y, Sozu T, Nakayama T, Kusao T, Kawakami T, Kojima K, Kojima H, Richmond J, Kleinstreuer N, Bae-Hwa K, Yamamoto Y, Fujita M, Kasahara T: A Multi-Centre Validation Study of Amino Acid Derivative Reactivity Assay (ADRA): A Novel In Chemico Alternative Test Method for Skin Sensitization, ,57th Annual meeting of Society of Toxicology (2018.3) (San Antonio, USA) 
  • Kojima H: New trend on alternative to animal testing in Japan, OpenTox 2018(2018.5)(Tokyo, Japan)
  • Kojima H: Alternative Test Methods Developed in Japan and South Korea for Regulatory Use, 8th Conference of Alternative Methods (2018.6) (Shanghai, China)
  • Kojima H: Recent Activities for safety assessment, International Symposium on Cosmetic Regulation (2018.7) (Tokyo, Japan)
  • Kojima H: An Introduction to the ICCR and Principles for the Safety Assessment of Cosmetic ingredients, The 2nd Asian Congress (2018.10) (Guangzhou, China)
  • Kojima H: Japanese Strategy on Alternative to Animal Test Methods for Systemic Toxicology, 20th International Congress on In Vitro Toxicology (2018.10) (Berlin, Germany)
  • Kojima H: Atsushi Ono, Masahiro Takeyoshi: Performance and future plan for EDCs testing and assessment in Japan, Current Status and Future Plan for Endocrine Disrupting Chemicals Testing and Assessment (2018.11) (Seoul, Korea)
  • Kojima H: JSAAE Promotion of the 3Rs in Asia, National Conference on Alternatives to Animal Experiments (NCAAE-2018) (2018.11) (New Delhi, India)
  • Kojima H: An Introduction to the ICCR and Principles for the Safety Assessment of Cosmetic ingredients, The 2nd Asian Congress (2018.10) (Guangzhou, China)
  • Kojima H: Japanese Strategy on Alternative to Animal Test Methods for Systemic Toxicology, 20th International Congress on In Vitro Toxicology (2018.10) (Berlin, Germany)
  • Kojima H, Atsushi Ono, Masahiro Takeyoshi: Performance and future plan for EDCs testing and assessment in Japan, Current Status and Future Plan for Endocrine Disrupting Chemicals Testing and Assessment (2018.11) (Seoul, Korea)
  • Kojima H: JSAAE Promotion of the 3Rs in Asia, National Conference on Alternatives to Animal Experiments (NCAAE-2018) (2018.11) (New Delhi, India)

Presentation